| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.077 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.088 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |